The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2020 | Mesothelioma: MARS 2 & MesoTRAP
Robert Rintoul, BSc, MBChB, FRCP, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, discusses the MARS 2 study (NCT02040272) which compares surgery (pleurectomy decortication) with no surgery with respect to overall survival, cost-effectiveness and quality of life. Dr Rintoul goes on to outline the MesoTRAP (NCT03412357) study comparing video-assisted thoracoscopic partial pleurectomy/decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.
